Report #2890304

Overview

Sex

Male

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

shingles in eye; This serious case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (Verbatim: shingles in eye) (serious criteria GSK medically significant). The outcome of the ophthalmic herpes zoster was not reported. It was unknown if the reporter considered the ophthalmic herpes zoster to be related to Shingles vaccine. The company considered the ophthalmic herpes zoster to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 12-MAR-2026 This case was reported via interactive digital media. The patient had the shingles vaccine and the next week he had shingles in eye. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Ophthalmic herpes zoster, 1 week after receiving Shingles vaccine, in a male patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.